Register Now

Welcome to Medical Device Playbook 2019
TORONTO

Medical Device Playbook is Canada’s largest Medtech event for entrepreneurial companies and medical device professionals. MDPLAYBOOK returns to the MaRS Discovery District on May 9, 2019.

Industry speakers and panels from the GTA and across North America will discuss, network and learn 2019 trends, opportunities, and strategies to Maximize Your Founder, Company and Device Value. Presentations include entrepreneur case studies, success stories, deal making, financing and clinical/regulatory advice from industry veterans.

Event includes Lunch, Breaks, and Networking Reception. Medical Device Playbook 2019 Toronto is co-hosted by StarFish Medical, MaRS, and OBIO. 

REGISTRATION NOW OPEN 

Toronto Speakers

  • Sameer Sabir

    Co-Founder and President of SevenOaks Biosystems

    + Show Bio

    From Academia to Acquisition: Closing the loop

    Panel: Boston's medtech ecosystem

  • Steve Arless

    Medical Technology Entrepreneur, Adjunct Professor, McGill University

    + Show Bio

    Success factors for selecting technologies and building high value startups

  • Jay Caplan

    Co-founder and President of Fractyl

    + Show Bio

    Invisible barriers to growth

    Lessons learned from experiences with InfraReDx and Fractyl

    Panel: Boston's medtech ecosystem

  • Peter Van der Velden

    Managing General Partner of Lumira Ventures

    + Show Bio

    Panel: Current & Future trends on medical device financing & partnerships

  • Randy AuCoin

    President and CEO of Exact Imaging

    + Show Bio

    Commercializing emerging medical technology – the Exact Imaging story

  • Joel Weinstein

    President, Principal at MAVEN Medical Device Strategies, Boston MA

    + Show Bio

    Panel: Boston's medtech ecosystem

  • Eric Tansky

    Managing Director, Healthcare, Oppenheimer & Co. Inc.

    + Show Bio

    Medical Device IPO and Partnership Landscape - US market point of view

    Panel: Current & Future trends on medical device financing & partnerships

  • Ali Ardakani

    Co-Founder & Managing Director of Novateur Ventures

    + Show Bio

    Panel: Current & Future trends on medical device financing & partnerships

  • Robert Kieval

    Chief Scientific and Clinical Officer, FemPulse Corporation

    + Show Bio

    Reflections on a 16-year startup: One entrepreneur’s experience

  • Dr. Sabina Bruehlmann

    Director of Technology and Co-Founder of Zephyr Sleep Technologies

    + Show Bio

    Successfully Navigating the De Novo pathway for FDA Clearance

  • Derek Mazur

    Investor at Santé Ventures

    + Show Bio

    Panel: Current & Future trends on medical device financing & partnerships

  • Ying Tam

    Managing Director of Health for MaRS Ventures

    + Show Bio

    Morning opening remarks

  • Gail Garland

    Founder and CEO of OBIO®

    + Show Bio

    Afternoon opening remarks: Achieving Impact Through Adoption of Innovative Health Technologies.

  • Vesna Janic

    Director of QA/RA, StarFish Medical

    + Show Bio

    Successfully Navigating the De Novo pathway for FDA Clearance

  • Scott Phillips

    CEO and Founder of StarFish Medical

    + Show Bio

    Analysis: Maximizing value for medtech founders, companies and devices

  • David Bell

    Account Executive at TUV SUD Canada

    + Show Bio

    Risk Management as per ISO 14971 and Home Healthcare Environment testing considerations as per IEC 60601-1-11

  • Parth Khanna

    Chief Executive Officer and Founder of ACTO

    + Show Bio

    4 Fundamentals: Your Clinical Evidence Stories Unlocked

  • Matthew Zischka

    Partner at Smart & Biggar/Fetherstonhaugh

    + Show Bio

    Networking Reception Welcome

Location

MARS Discovery District
MaRS Centre Auditorium
Lower Concourse level of the South Tower
101 College Street, Suite 100
Toronto, ON M5G 1L7
Canada

92% would recommend the event to friends

 “It is the only ‘conference’ of its type in Canada. I really enjoyed that it was all about the business and commercialization aspects of the health-tech industry and not heavily based on technology.”